Daytime Dysfunction: Symptoms Associated with Nervous System Disorders Mediated by SIRT1.

SIRT1 daytime dysfunction memory and cognition sleep–wake

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
11 Sep 2024
Historique:
received: 06 07 2024
revised: 24 08 2024
accepted: 30 08 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Daytime dysfunction, including symptoms like sleepiness, poor memory, and reduced responsiveness, is not well researched. It is crucial to develop animal models and study the biological mechanisms involved. We simulated sleep disorders through sleep deprivation, and stressful stimuli were used to establish daytime functional animal models. We used tests like the sodium pentobarbital sleep synergy test and the DSI telemetry system to measure sleep duration and structure. We also used tests like the Morris water maze, open field test, grip test, and baton twirling test to assess mental and physical fatigue. To assess the intrinsic biological mechanisms, we measured sleep-wake-related neurotransmitters and related receptor proteins, circadian rhythm-related proteins and cognition-related proteins in hypothalamus tissue, and oxidative stress, inflammatory factors, S100β, and HPA axis-related indexes in serum. Multi-factor sleep deprivation resulted in the disruption of sleep-wakefulness structure, memory-cognitive function degradation, decreased grip coordination, and other manifestations of decreased energetic and physical strength. The intrinsic biological mechanisms were related to the disturbed expression of sleep-wake, circadian rhythm, memory-cognition-related proteins, as well as the significant elevation of inflammatory factors, oxidative stress, the HPA axis, and other related indicators. Intrinsically related biological mechanisms and reduced sirt1 expression can lead to disruption of circadian rhythms; resulting in disruption of their sleep-wake-related neurotransmitter content and receptor expression. Meanwhile, the reduced expression of sirt1 also resulted in reduced expression of synapse-associated proteins. This study prepared an animal model of daytime dysfunction by means of multi-factor sleep deprivation. With sirt1 as a core target, the relevant biological mechanisms of neurological disorders were modulated.

Identifiants

pubmed: 39335583
pii: biomedicines12092070
doi: 10.3390/biomedicines12092070
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : special qualification of cultivating and improving the military Chinese medicine service ability
ID : 2023ZY063
Organisme : National Natural Science Foundation of China
ID : NO. 82004054
Organisme : Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
ID : No: ZYYCXTD-D-202207

Auteurs

Tianke Huang (T)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Xianxie Zhang (X)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Ling Qi (L)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Fang Li (F)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Zuoxu Liu (Z)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Zhixing Wang (Z)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Yi Ru (Y)

Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Maoxing Li (M)

Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing 100853, China.

Chengrong Xiao (C)

Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Yuguang Wang (Y)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing 100853, China.

Zengchun Ma (Z)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Yue Gao (Y)

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing 100853, China.

Classifications MeSH